The avión replete of vacabas acababa to aterrizar at the airport of Santiago to fines of January and the President of Chilean Sebastián Piñera will show jubilant. “Today is a day of allegiance, emotion and hope,” the mandate said.
The source of this hope: China, a country of Chile and other decades of nations dependent on aid to end the COVID-19 pandemic.
China’s diplomatic campaign on the issue of vacancies has a surprising success: A compromise has been reached to distribute 500 million doses among more than 45 countries, following a country-by-country investigation by The Associated Press. Four laboratories that produce the vaccine in China have produced at least 2,600 million doses this year, guaranteeing that good parts of the global population will be inoculated with the public vacancies advertised, produced with the most modest Chinese vaccine produced by methods traditional.
I do not know much about China’s vacancies and I have no doubt about its efficiencies and reliability, without mentioning that China can feed them. But it has started the inoculations in more than 25 countries and has been involved in other 11, according to the AP’s report, based on informing Independents of their nations and in official announcements and companies.
This success has helped a small town to eradicate the bad image and dissonance generated by the initial maneuver of the pandemic on the part of China, the country where the broth originated.
We are presenting a diploma of vacancies. China is a vanguard in the production of vacancies, which is at the disposal of others ”, comments Krishna Udayakumar, founder and director of Centro Global de Innovation en la Salud de la Universidad de Duke.
China says it is “helping with vacancies” in 53 countries and that exports to 27, but does not summarize the list of nations that received the AP. Beijing does not hold diplomacy with vacancies and a spokesman for the Ministry of External Relations says that Beijing considers vacancies “a world public good”. Chinese experts are making some connections between the export of vacancies and efforts to improve the image of the country.
China is in the throes of the floods of mediocre medians that come with the rich nations that support the majority of vacancies produced by laboratories such as Pfizer and Modern. In spite of some demonstrations, China has approved the slow distribution of vehicles by United States and European laboratories.
However other nations, Chile receives lower doses of Pfizer’s vaccine than those promised. The Chinese company Sinovac responded quickly and summed up 4 million doses.
Chile and the other nations of the heavens and medians ingress ten small options. The distribution of vacancies at the global level has been dominated by rich countries, which cover 5,400 million of the 7,800 million of the required dose worldwide, according to the University of Duke.
Chinese vacancies, which can be used in normal refrigerators, are attractive to nations that can have problems with extremely low temperature conservation, as required by Pfizer and other vacancies.
Sinovac and Sinopharm are products with traditional technology, in which a live virus is eliminated and purified, generating a response from the immunological system. Some countries consider it more secure that the products have a newer technology, a little tried, circulating in the West and that they have a viral specimen, due to the lack of information about the reliability of Chinese vacancies.
China is receiving vacancies including countries such as Serbia and Hungary, which constitute an important geopolitical victory in Central Europe and the Balkans, while Occidente, China and Russia have begun to gain political and economic influence. Hungary is the first country in the European Union to relocate to China.
The diplomacy of the vacancies will always work and when the vacancies function, and in this area there are some doubts.
“There is little information available about the Chinese vaccine, compared to other vaccines,” said Ahmed Hamdan Zayed, an Egyptian nurse who raised his initial resistance and was evacuated to Sinopharm.
Sinopharm says its vaccine has a 79% efficacy, according to internal clinical trials. No answer is a pedidos de entrevistas.
In Brazil, the authorities are reviewing the efficacy of Sinovac, reimbursing 78% to 50% including liver infections.
A panel of experts in Hong Kong’s public information related to Sinovac en los reguladores sanitarios según la cual la efectividad era del 50%.
Sanitary authorities say that anyone evacuated with a minimum of 50% is utilized.
The severity of the pandemic makes the countries ignore the dudes who can be near the Chinese vaccine.
“The vacancies, about all the products in the Occident, are reserved for the rich lands,” said an Egyptian official, who did not identify himself as the subject. “We are looking for a vacancy. Any vacuna ”.